En direct

Le Centre de Recherche en Cancérologie de Marseille fête ses 50 ans ! -

May 2012 Oncoimmunology

« Stealth » tumors: Breast cancer cells shun NK-cells anti-tumor immunity.


Breast cancers (BCs) comprise heterogeneous subtypes of various prognoses. An active anti-tumor immune profile usually correlated with a better survival. Two current major challenges of BC research are to understand the inter-relations between BC and anti-tumor immunity, and to identify candidates whose targeting would contribute to enhance anti-tumor efficiency.

Lire l‘article